Godzilla vs. Mighty Morphin Power Rangers


Book Description

The King of the Monsters and the defenders of Earth take on villains from both their worlds in this crossover clash for the ages! When the evil sorceress Rita Repulsa retrieves the multiversal focus—a gemstone through which all realities can be seen—she sets her sights on an alternate Earth where the Power Rangers don’t exist to interfere with her nefarious plans! But what she finds instead are a race of alien conquerors known as the Xiliens, who are unleashing unpredictable Kaiju in the hopes of defeating Godzilla and taking over the planet. As the two join forces, they find their goals interrupted by the arrival of the Power Rangers! Can they and Godzilla stop the threat before it’s too late? Collects the five-issue crossover event.







The NIV Exhaustive Concordance


Book Description

Concordance based on the New international version of the Bible gives complete access to every word of the NIV text as well as to the Hebrew, Aramaic, and Greek terms from which the NIV was translated. Also cross-references some 2,000 key words from the King James version to their NIV equivalents. Annotation copyrighted by Book News, Inc., Portland, OR




Indian Trade Journal


Book Description










Chemical Abstracts


Book Description







Genome Stability


Book Description

Genome Stability: From Virus to Human Application, Second Edition, a volume in the Translational Epigenetics series, explores how various species maintain genome stability and genome diversification in response to environmental factors. Here, across thirty-eight chapters, leading researchers provide a deep analysis of genome stability in DNA/RNA viruses, prokaryotes, single cell eukaryotes, lower multicellular eukaryotes, and mammals, examining how epigenetic factors contribute to genome stability and how these species pass memories of encounters to progeny. Topics also include major DNA repair mechanisms, the role of chromatin in genome stability, human diseases associated with genome instability, and genome stability in response to aging. This second edition has been fully revised to address evolving research trends, including CRISPRs/Cas9 genome editing; conventional versus transgenic genome instability; breeding and genetic diseases associated with abnormal DNA repair; RNA and extrachromosomal DNA; cloning, stem cells, and embryo development; programmed genome instability; and conserved and divergent features of repair. This volume is an essential resource for geneticists, epigeneticists, and molecular biologists who are looking to gain a deeper understanding of this rapidly expanding field, and can also be of great use to advanced students who are looking to gain additional expertise in genome stability. - A deep analysis of genome stability research from various kingdoms, including epigenetics and transgenerational effects - Provides comprehensive coverage of mechanisms utilized by different organisms to maintain genomic stability - Contains applications of genome instability research and outcomes for human disease - Features all-new chapters on evolving areas of genome stability research, including CRISPRs/Cas9 genome editing, RNA and extrachromosomal DNA, programmed genome instability, and conserved and divergent features of repair




Chemosensitivity


Book Description

A state-of-the art collection of readily reproducible laboratory methods for assessing chemosensitivity in vitro and in vivo, and for assessing the parameters that modulate chemosensitivity in individual tumors. Chemosensitivity,Volume 2: In Vivo Models, Imaging, and Molecular Regulators contains cutting-edge protocols for classifying tumors into response categories and for customizing therapy to individuals. These readily reproducible techniques allow measurements of DNA damage, apoptotic cell death, and the molecular and cellular regulators of cytotoxicity, as well as in vivo animal modeling of chemosensitivity. A companion volume, Volume 1: In Vitro Assays contains in vitro and in vivo techniques to identify which new agents or combination of agents are effective for each type of tumor.